Distribution of NHS medicines during Olympics: new communications pack published

The British Association of Pharmaceutical Wholesalers (BAPW) has published a new pack that explains how the distribution of NHS medicines to hospitals and pharmacies is being managed during the Olympic and Paralympic Games.

Page Content

The BAPW's London 2012 Medicines Supply Chain Communications Pack is available to download here.

A specialised distribution service to hospitals and pharmacies will be in operation, from this week, to minimise the impact of the Olympic Games on medicines distribution.

During the Olympic period the ABPI will be taking part in regular conference calls with the Department of Health and BAPW to ensure lines of communication are open regarding any issues that supply chain stakeholders may experience.

Get in touch

I am happy for ABPI to keep my details on file and to send me details of future ABPI work and services. ABPI will not sell your data to any third party or send you any information about products or services that ABPI has no direct connection with.

The Association of the British Pharmaceutical Industry

is a company limited by guarantee registered in England and Wales
(registered number 09826787) and its registered office is at
7th Floor Southside,105 Victoria Street, London, SW1E 6QT.
Telephone +44 (0) 207 9303477

The Prescription Medicines Code of Practice Authority (PMCPA) was established by The Association of the British Pharmaceutical Industry to operate the ABPI Code of Practice for the Pharmaceutical Industry independently of the ABPI. The PMCPA is a division of ABPI which is a company registered in England and Wales (registered number 09826787) with its registered office at 7th Floor, Southside, 105 Victoria Street, London SW1E 6QT.

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 7th Floor Southside, 105 Victoria Street, London, SW1E 6QT. OHE provides independent research, advisory and consultancy services on policy implications and economic issues within the pharmaceutical, health care and biotechnology sectors.